Dr. Nirav Niranjan Shah explains the data behind why autologous stem cell transplant should remain the standard of care for patients with relapsed chemo-sensitive DLBCL.
Nirav Niranjan Shah, MD
Advertisement
Articles by Nirav Niranjan Shah, MD
Advertisement
Latest Updated Articles
Autologous Stem Cell Transplant Should Remain Standard of Care for Certain DLBCL Patients, Expert SaysPublished: June 9th 2020 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Key Blood Cancer Advances for Patients From the 2025 ASH Annual Meeting
2
Dave Coulier Embraces Positivity Amid a Second Cancer Diagnosis
3
What No One Tells You About Life After Breast Cancer: Fighting for Care
4
A Patient’s Journey Through Remission and Mental Health With Non-Hodgkin Lymphoma
5